z-logo
Premium
Non‐aneurysmal subarachnoid hemorrhage in 173 patients: a prospective study of long‐term outcome
Author(s) -
Konczalla J.,
Schmitz J.,
Kashefiolasl S.,
Senft C.,
Seifert V.,
Platz J.
Publication year - 2015
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.12762
Subject(s) - medicine , subarachnoid hemorrhage , modified rankin scale , vasospasm , ischemia , ischemic stroke
Background and purpose In some patients with subarachnoid hemorrhage ( SAH ) a bleeding source cannot be identified. Perimesencephalic ( PM ) SAH is assumed to have an excellent outcome. Our objective was to analyze the long‐term physical and psychological outcome of patients after non‐aneurysmal SAH . Methods One hundred and seventy‐three patients met the inclusion criteria. Short‐term follow‐up 6 months after SAH was assessed according to the modified Rankin Scale (0–2 favorable). A short‐form health survey with 36 questions ( SF ‐36) and eight scales was used as questionnaire for long‐term follow‐up. Results Thirty‐seven answers were received from the two groups, PM and non‐perimesencephalic ( NPM ) SAH , on average 76 months after ictus (range 1.5–14 years). PM ‐ and NPM ‐ SAH without Fisher grade 3 blood pattern have excellent short‐term outcomes. The quality of life (QoL) is significantly reduced after non‐aneurysmal SAH , especially in NPM ‐ SAH . In particular, patients with a Fisher 3 blood pattern had significantly higher risks for cerebral vasospasm, delayed cerebral ischaemia, unfavorable outcome, reduced QoL and mortality in short‐ and long‐term follow‐up. Conclusions Excluding rolph, only patients with a PM ‐ SAH have a similar QoL at long‐term follow‐up compared to the standard population. Patients with NPM ‐ SAH have a significantly decreased QoL in long‐term follow‐up. Furthermore, the Fisher 3 blood pattern group in particular had a significantly worse outcome − at short‐term and long‐term follow‐up. Therefore the NPM ‐ SAH group was stratified into patients with Fisher 3 blood pattern and patients without Fisher 3 in further investigations.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom